Key result
Lower eGDR is linked to ~28% higher incident heart failure risk per 1-unit decrease.
Why the study?
Reduced estimated glucose disposal rate (eGDR) has been linked to cardiovascular disease, but its associations with myocardial fibrosis and heart failure remain unclear.
Does lower estimated glucose disposal rate (eGDR) predict incident heart failure and myocardial fibrosis in adults free of cardiovascular disease at baseline?
Cohort (n=6,025)
Yes
Does lower estimated glucose disposal rate (eGDR) predict incident heart failure and myocardial fibrosis in adults free of cardiovascular disease at baseline?
Hazard Ratio: 1.28 (95% CI 1.22–1.35)
The estimated glucose disposal rate (eGDR) is a simple, clinically accessible marker of insulin resistance that independently predicts incident heart failure and subclinical myocardial fibrosis.
May flag higher HF risk via routine eGDR; leaves open whether targeting insulin resistance prevents incident HF.
BACKGROUND: Heart failure (HF) is increasingly driven by cardiometabolic risk factors such as obesity and insulin resistance. The estimated glucose disposal rate (eGDR) is a validated surrogate marker of insulin resistance. Reduced eGDR, reflecting higher insulin resistance, has been linked to cardiovascular disease, but its associations with myocardial fibrosis and HF remain unclear. METHODS: The study included 6025 participants in MESA (Multi-Ethnic Study of Atherosclerosis) free of HF at exam 2 (2002-2004). eGDR was calculated using body mass index, hypertension, and hemoglobin A1c. Cardiac magnetic resonance imaging (2010-2012) assessed left ventricular ejection fraction and myocardial fibrosis by late gadolinium enhancement. Associations of baseline eGDR with incident HF were evaluated using Cox models, stratified by diabetes. RESULTS: Over a mean follow-up of 14±5 years, 404 participants developed HF. eGDR was inversely associated with incident HF (adjusted hazard ratio [HR] per unit decrease, 1.28 [95% CI, 1.22-1.35]), a relationship that persisted regardless of diabetes status and was more pronounced for HF with preserved ejection fraction (n=200; adjusted HR per unit decrease, 1.36 [95% CI, 1.27-1.45]) than HF with reduced ejection fraction (n=168; HR, 1.19 [95% CI, 1.11-1.27]). Lower eGDR was also associated with higher left ventricular ejection fraction (n=2899; β=0.16, [95% CI, 0.03-0.28]) and higher odds of myocardial fibrosis (n=1780; adjusted odds ratio, 1.27 [95% CI, 1.16-1.41]). CONCLUSIONS: Lower eGDR is independently associated with subclinical myocardial damage and incident HF, highlighting insulin resistance as a key driver of adverse remodeling and a potential marker for early HF risk stratification and prevention.
No takes yet. Share an insight, caveat, or question.
Bukhari et al. (2026) conducted a cohort in Free of heart failure and clinical cardiovascular disease at baseline (n=6,025). Estimated glucose disposal rate (eGDR) vs. Higher eGDR (per 1-unit increase) was evaluated on Incident heart failure events (HR 1.28, 95% CI 1.22-1.35). Lower estimated glucose disposal rate was independently associated with an increased risk of incident heart failure (adjusted HR 1.28 per 1-unit decrease).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: